IMPAIRED ENDOTHELIAL FUNCTION OCCURS IN THE SYSTEMIC ARTERIES OF CHILDREN WITH HOMOZYGOUS HOMOCYSTINURIA BUT NOT IN THEIR HETEROZYGOUS PARENTS

被引:225
作者
CELERMAJER, DS [1 ]
SORENSEN, K [1 ]
RYALLS, M [1 ]
ROBINSON, J [1 ]
THOMAS, O [1 ]
LEONARD, JV [1 ]
DEANFIELD, JE [1 ]
机构
[1] HOSP SICK CHILDREN,MED UNIT,LONDON WC1N 3JH,ENGLAND
关键词
D O I
10.1016/0735-1097(93)90203-D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Because endothelial dysfunction is an early event in atherogenesis, we aimed to determine whether endothelial function is normal or impaired in the systemic arteries of children with homozygous homocystinuria or in those of heterozygous adults, or both. Background. Homocystinuria is strongly associated with premature vascular disease in homozygotes, and even heterozygotes have been shown to be at increased risk from early atherosclerosis associated with hyperhomocystinemia. Methods. We conducted noninvasive studies on the superficial femoral or brachial arteries of 9 children aged 4 to 17 years (mean 11) with homozygous homocystinuria and on the brachial arteries of 14 obligate heterozygote parents aged 33 to 49 years (mean 41). Each subject was matched with two control subjects. Using high resolution ultrasound, we measured vessel diameter at rest, during reactive hyperemia (with flow increase causing endothelium-dependent dilation) and after sublingual administration of nitroglycerin (an endothelium-independent vasodilator). Results. Flow-mediated dilation was observed in the control children (9 +/- 0.6%, range 6% to 14%) but was impaired in the children with homocystinuria (2.8 +/- 0.7%, range 0% to 7%, p < 0.0001). In contrast, nitroglycerin-mediated dilation was similar in both groups (15.7 +/- 1.6% vs. 13.1 +/- 1.2%, p = 0.27), indicating that the impaired flow-mediated dilation is secondary to endothelial dysfunction. In the heterozygous parents, both flow-mediated dilation and nitroglycerin responses (6.3 +/- 0.9%, 17 +/- 1.4%, respectively) were similar to control values (6.8 +/- 0.7%, 20.7 +/- 1.7%, p > 0.10). Conclusions. Children with homozygous homocystinuria had impaired endothelial function in the systemic arteries as early as 4 years of age, representing an early event in their premature vascular disease. However, endothelial function was preserved in the heterozygous adults.
引用
收藏
页码:854 / 858
页数:5
相关论文
共 33 条
[1]   HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE [J].
BOERS, GHJ ;
SMALS, AGH ;
TRIJBELS, FJM ;
FOWLER, B ;
BAKKEREN, JAJM ;
SCHOONDERWALDT, HC ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :709-715
[2]   MODERATE HOMOCYSTEINEMIA - A POSSIBLE RISK FACTOR FOR ARTERIOSCLEROTIC CEREBROVASCULAR-DISEASE [J].
BRATTSTROM, LE ;
HARDEBO, JE ;
HULTBERG, BL .
STROKE, 1984, 15 (06) :1012-1016
[3]   NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS [J].
CELERMAJER, DS ;
SORENSEN, KE ;
GOOCH, VM ;
SPIEGELHALTER, DJ ;
MILLER, OI ;
SULLIVAN, ID ;
LLOYD, JK ;
DEANFIELD, JE .
LANCET, 1992, 340 (8828) :1111-1115
[4]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[5]   IMPAIRED VASODILATION OF FOREARM RESISTANCE VESSELS IN HYPERCHOLESTEROLEMIC HUMANS [J].
CREAGER, MA ;
COOKE, JP ;
MENDELSOHN, ME ;
GALLAGHER, SJ ;
COLEMAN, SM ;
LOSCALZO, J ;
DZAU, VJ .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :228-234
[6]   EFFECT OF HOMOCYSTEINE AND HOMOCYSTINE ON PLATELET AND VASCULAR ARACHIDONIC-ACID METABOLISM [J].
GRAEBER, JE ;
SLOTT, JH ;
ULANE, RE ;
SCHULMAN, JD ;
STUART, MJ .
PEDIATRIC RESEARCH, 1982, 16 (06) :490-493
[7]   HOMOCYSTINE-INDUCED ARTERIOSCLEROSIS - ROLE OF ENDOTHELIAL CELL INJURY AND PLATELET RESPONSE IN ITS GENESIS [J].
HARKER, LA ;
ROSS, R ;
SLICHTER, SJ ;
SCOTT, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (03) :731-741
[8]   RESTORATION OF ENDOTHELIUM-DEPENDENT RELAXATION BY DIETARY-TREATMENT OF ATHEROSCLEROSIS [J].
HARRISON, DG ;
ARMSTRONG, ML ;
FREIMAN, PC ;
HEISTAD, DD .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (06) :1808-1811
[9]  
HEINECKE JW, 1987, J BIOL CHEM, V262, P10098
[10]  
HOLTZ J, 1984, J CARDIOVASC PHARM, V6, P1161